A new trading day began on Friday, with Zai Lab Limited ADR (NASDAQ: ZLAB) stock price up 4.29% from the previous day of trading, before settling in for the closing price of $26.36. ZLAB’s price has ranged from $13.48 to $31.22 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Healthcare Sector giant saw their annual sales surged by 2095.12% over the last five years. Meanwhile, its annual earnings per share averaged 13.83%. With a float of $98.53 million, this company’s outstanding shares have now reached $99.12 million.
The firm has a total of 2175 workers. Let’s measure their productivity. In terms of profitability, gross margin is 62.95%, operating margin of -109.67%, and the pretax margin is -92.44%.
Zai Lab Limited ADR (ZLAB) Breakdown of a Key Holders of the stock
As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of Zai Lab Limited ADR is 0.59%, while institutional ownership is 42.63%. The most recent insider transaction that took place on Oct 02 ’24, was worth 7,645. In this transaction Chief Financial Officer of this company sold 301 shares at a rate of $25.40, taking the stock ownership to the 15,161 shares. Before that another transaction happened on Oct 02 ’24, when Company’s Officer proposed sale 301 for $25.40, making the entire transaction worth $7,645.
Zai Lab Limited ADR (ZLAB) Recent Fiscal highlights
In its latest quarterly report, released on 6/30/2024, the company reported earnings of -0.71 per share, which was $0.1 higher than the consensus estimate of $0.26. In terms of return on equity, this company recorded -19.55% in contrast with 50.0% return on Investment (trailing twelve months). Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.78 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 13.83% per share during the next fiscal year.
Zai Lab Limited ADR (NASDAQ: ZLAB) Trading Performance Indicators
Here are Zai Lab Limited ADR’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 3.29. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 8.44.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -3.07, a number that is poised to hit -0.76 in the next quarter and is forecasted to reach -1.73 in one year’s time.
Technical Analysis of Zai Lab Limited ADR (ZLAB)
Analysing the last 5-days average volume posted by the [Zai Lab Limited ADR, ZLAB], we can find that recorded value of 0.86 million was better than the volume posted last year of 0.64 million. As of the previous 9 days, the stock’s Stochastic %D was 71.41%. Additionally, its Average True Range was 1.35.
During the past 100 days, Zai Lab Limited ADR’s (ZLAB) raw stochastic average was set at 89.76%, which indicates a significant increase from 74.31% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 54.05% in the past 14 days, which was higher than the 49.67% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $21.20, while its 200-day Moving Average is $19.54. Now, the first resistance to watch is $28.41. This is followed by the second major resistance level at $29.34. The third major resistance level sits at $29.87. If the price goes on to break the first support level at $26.95, it is likely to go to the next support level at $26.42. Now, if the price goes above the second support level, the third support stands at $25.49.
Zai Lab Limited ADR (NASDAQ: ZLAB) Key Stats
With a market capitalization of 2.72 billion, the company has a total of 99,609K Shares Outstanding. Currently, annual sales are 266,720 K while annual income is -334,620 K. The company’s previous quarter sales were 100,500 K while its latest quarter income was -80,280 K.
